Next 10 |
Glass Lewis Concludes That Support is Merited for AREX Nominees to Add “Fresh Perspectives and Relevant Expertise” Two Leading Independent Proxy Advisory Firms Recognize That Boardroom Change is Urgently Needed at Enhabit AREX Capital Management, LP (together...
2024-07-15 10:00:00 ET Summary It is soon to be the last independent home health and hospice company. Scarcity value could drive interest from financial and strategic bidders. Shareholders have a slate of new directors to refresh the company. I disclosed my position ...
2024-07-15 08:02:18 ET More on Enhabit Enhabit investors urged by ISS to back three AREX board nominees Enhabit challenged by hedge fund AREX Capital seeking seven board seats - report Read the full article on Seeking Alpha For further details see: Enhabi...
Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), a leading home health and hospice provider, today announced certain unaudited preliminary results for the second quarter ended June 30, 2024. The Company plans to report actual second quarter 2024 financial resul...
2024-07-12 14:17:05 ET More on Enhabit Enhabit, Inc. (EHAB) Q1 2023 Earnings Call Transcript Enhabit challenged by hedge fund AREX Capital seeking seven board seats - report Enhabit concludes review of strategic alternatives Seeking Alpha’s Quant Ratin...
ISS Concludes Support Is Warranted for AREX Nominees to Add Beneficial Industry-Specific Expertise and “Oversight Over the Company's Financial Reporting and Shareholder Communications” ISS Recognizes “The Most Apparent Needs for the Board Are Additional Expertise ...
ISS Recognizes that Enhabit’s Performance Over the Last Two Quarters is Promising and Several Underlying Metrics Point to Building Momentum Recommendation Does Not Account for the Significant Expertise and Valuable Oversight Gregory Rush, Erin Hoeflinger and Susan La Monica Bring t...
Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the second quarter ended June 30, 2024, on Aug. 6, 2024, and host a webcast and conference call on Aug. 7, 2024. Individuals who would like to participate in the confe...
AREX’s Slate of Less Experienced and Unqualified Director Candidates – and its Planned Formation of a “Transformation Committee” – Threatens to Destabilize Enhabit Urges Stockholders to Vote FOR Enhabit’s Director Nominees on the YELLOW Proxy Card...
Highlights Enhabit’s Disappointing Total Stockholder Return Believes Evidence Is Overwhelming that Enhabit’s Strategies Are Not Working Emphasizes Enhabit’s Repeated Pattern of Making Promises It Does Not Keep and Claiming Progress It Has Not Achieved ...
News, Short Squeeze, Breakout and More Instantly...
Glass Lewis Concludes That Support is Merited for AREX Nominees to Add “Fresh Perspectives and Relevant Expertise” Two Leading Independent Proxy Advisory Firms Recognize That Boardroom Change is Urgently Needed at Enhabit AREX Capital Management, LP (together...
Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), a leading home health and hospice provider, today announced certain unaudited preliminary results for the second quarter ended June 30, 2024. The Company plans to report actual second quarter 2024 financial resul...
ISS Concludes Support Is Warranted for AREX Nominees to Add Beneficial Industry-Specific Expertise and “Oversight Over the Company's Financial Reporting and Shareholder Communications” ISS Recognizes “The Most Apparent Needs for the Board Are Additional Expertise ...